O'Keefe Stevens Advisory's Q2 2026 letter underscores persistent strength in AI-driven equities, with portfolio positioning reflecting confidence in semiconductor and technology infrastructure plays. The firm's emphasis on NVDA and AAPL as portfolio leaders signals conviction that artificial intelligence monetization narratives remain intact, supporting valuations in a period where earnings growth must sustain elevated multiples.
The advisory's new position in Sotera Health (SHC) introduces a healthcare exposure angle, suggesting rotation toward beneficiaries of AI adoption in medical devices and diagnostics. This allocation broadens the fund's thematic reach beyond pure-play semiconductor and cloud infrastructure, indicating belief that AI's commercial application spans both traditional tech and adjacent sectors with strong margin profiles.
Q2 2026 performance metrics imply the portfolio benefited from continued momentum in mega-cap technology names, though the timing and composition of new stakes warrant scrutiny regarding valuation entry points and sector concentration risk. The healthcare addition may reflect either opportunistic positioning or a recognition that growth is broadening beyond traditional AI hardware dominance.
Sector implication: This portfolio construction demonstrates sustained Technology sector leadership with nascent diversification into Health Care. The bullish tilt suggests institutional conviction in AI's sustained commercial value creation, though the lack of defensive or counter-cyclical positioning leaves the portfolio correlated with continued risk-asset appreciation and vulnerable to multiple compression.